{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:19:01Z","timestamp":1790893141145,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.pupt.2023.102233","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T11:59:14Z","timestamp":1688471954000},"page":"102233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Safety and usefulness of nebulized liposomal amphotericin B: Systematic scoping review"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-1891","authenticated-orcid":false,"given":"Hideharu","family":"Hagiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2023.102233_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.pupt.2023.102233_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.pupt.2023.102233_bib3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.healun.2003.09.028","article-title":"A survey of anti-fungal management in lung transplantation","volume":"23","author":"Dummer","year":"2004","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.pupt.2023.102233_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-3062.2006.00156.x","article-title":"Variation in antifungal prophylaxis strategies in lung transplantation","volume":"8","author":"Husain","year":"2006","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.TP.0000101516.08327.A9","article-title":"Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients","volume":"77","author":"Drew","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.pupt.2023.102233_bib6","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1345\/aph.1G477","article-title":"Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections","volume":"40","author":"Mohammad","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pupt.2023.102233_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.healun.2009.11.603","article-title":"Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation","volume":"29","author":"Monforte","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.pupt.2023.102233_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pupt.2023.102233_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jclinepi.2020.03.016","article-title":"Reporting scoping reviews-PRISMA ScR extension","volume":"123","author":"McGowan","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pupt.2023.102233_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1179\/joc.2007.19.3.339","article-title":"Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder","volume":"19","author":"Castagnola","year":"2007","journal-title":"J. Chemother."},{"key":"10.1016\/j.pupt.2023.102233_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1399-3062.2009.00423.x","article-title":"Cutaneous aspergillosis in a lung transplant recipient","volume":"11","author":"Ramos","year":"2009","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.riam.2011.06.005","article-title":"Aspergillus tracheobronchitis in a lung transplant recipient","volume":"28","author":"Garc\u00eda-Gallo","year":"2011","journal-title":"Rev. Iberoam. De. Micol."},{"key":"10.1016\/j.pupt.2023.102233_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.201311-2086LE","article-title":"Nebulized liposomal amphotericin B for treating Aspergillus empyema with bronchopleural fistula","volume":"189","author":"Hanada","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102233_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/1973947814Y.0000000194","article-title":"Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: case report and review of literature","volume":"27","author":"Casciaro","year":"2015","journal-title":"J. Chemother."},{"key":"10.1016\/j.pupt.2023.102233_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/myc.12294","article-title":"Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review","volume":"58","author":"Godet","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.pupt.2023.102233_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11046-015-9891-4","article-title":"Treatment of disseminated Talaromyces marneffei with tracheal infection: two case reports","volume":"180","author":"Qiu","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.pupt.2023.102233_bib17","article-title":"Invasive microascus trigonosporus species complex pulmonary infection in a lung transplant recipient","volume":"2015","author":"Schoeppler","year":"2015","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.pupt.2023.102233_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11046-017-0117-9","article-title":"Nebulized liposomal amphotericin B for treatment of pulmonary infection caused by hormographiella aspergillata: case report and literature review","volume":"182","author":"Godet","year":"2017","journal-title":"Mycopathologia"},{"key":"10.1016\/j.pupt.2023.102233_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/02770903.2018.1429467","article-title":"Efficacy of nebulized liposomal amphotericin B in the treatment of ABPA in an HIV\/HBV co-infected man: case report and literature review","volume":"56","author":"Garcia","year":"2019","journal-title":"J. Asthma"},{"key":"10.1016\/j.pupt.2023.102233_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijid.2020.06.003","article-title":"Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate","volume":"97","author":"Basile","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib21","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2169\/internalmedicine.6305-20","article-title":"Successful treatment of antifungal combination therapy with inhaled liposomal amphotericin B and oral voriconazole for intractable chronic progressive pulmonary aspergillosis","volume":"60","author":"Hamada","year":"2021","journal-title":"Intern. Med."},{"key":"10.1016\/j.pupt.2023.102233_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13501","article-title":"Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient","volume":"23","author":"Trujillo","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1399-3062.2007.00209.x","article-title":"Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study","volume":"9","author":"Lowry","year":"2007","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib24","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.transproceed.2009.06.018","article-title":"A comparision of several formats of amphotericin B as an inhaled antifungal prophylaxis","volume":"41","author":"SanMart\u00edn","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.pupt.2023.102233_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2008.11.004","article-title":"Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety","volume":"28","author":"Monforte","year":"2009","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.pupt.2023.102233_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.healun.2012.11.013","article-title":"Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant","volume":"32","author":"Monforte","year":"2013","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.pupt.2023.102233_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijantimicag.2015.02.023","article-title":"Aerosolised liposomal amphotericin B to prevent aspergillosis in acute Myeloid Leukaemia: efficacy and cost effectiveness in real-life","volume":"46","author":"Chong","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.pupt.2023.102233_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/tid.12492","article-title":"Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients","volume":"18","author":"Peghin","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/tri.12679","article-title":"10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation","volume":"29","author":"Peghin","year":"2016","journal-title":"Transpl. Int."},{"key":"10.1016\/j.pupt.2023.102233_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13448","article-title":"Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation","volume":"23","author":"Linder","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-021-03728-w","article-title":"Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis\/aspergillus tracheobronchitis","volume":"25","author":"Van Ackerbroeck","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.pupt.2023.102233_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.874117","article-title":"Results of an innovative program for surveillance, prophylaxis, and treatment of infectious complications following allogeneic stem cell transplantation in hematological malignancies (BATMO protocol)","volume":"12","author":"Malagola","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.pupt.2023.102233_bib33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pupt.2008.09.001","article-title":"Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial","volume":"21","author":"Slobbe","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2023.102233_bib35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000327802","article-title":"Prophylactic application of nebulized liposomal amphotericin B in hematologic patients with neutropenia","volume":"34","author":"Hullard-Pulstinger","year":"2011","journal-title":"Onkologie"},{"key":"10.1016\/j.pupt.2023.102233_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13832","article-title":"Antifungal prophylaxis in adult lung transplant recipients: uncertainty despite 30 years of experience. A systematic review of the literature and network meta-analysis","volume":"24","author":"Marinelli","year":"2022","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/clind\/15.4.654","article-title":"Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides","volume":"15","author":"Karlowsky","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102233_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4155\/tde.14.13","article-title":"Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa","volume":"5","author":"Alipour","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.pupt.2023.102233_bib39","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s40265-020-01359-z","article-title":"Inhaled liposomal antimicrobial delivery in lung infections","volume":"80","author":"Bassetti","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.pupt.2023.102233_bib40","article-title":"Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers","volume":"635","author":"de Pablo","year":"2023","journal-title":"Int. J. Pharm. (Amst.)"},{"key":"10.1016\/j.pupt.2023.102233_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2020.101975","article-title":"Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles\/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery","volume":"64","author":"Gomez","year":"2020","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2023.102233_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/jamp.2022.0003","article-title":"Preclinical studies of the nebulized delivery of liposomal amphotericin B","volume":"35","author":"Sagar","year":"2022","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553923000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553923000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:31:40Z","timestamp":1761082300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553923000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":42,"alternative-id":["S1094553923000457"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2023.102233","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and usefulness of nebulized liposomal amphotericin B: Systematic scoping review","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2023.102233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102233"}}